Dimensional Fund Advisors LP Sells 12,456 Shares of The Beauty Health Company (NASDAQ:SKIN)

Dimensional Fund Advisors LP reduced its holdings in shares of The Beauty Health Company (NASDAQ:SKIN) by 12.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 89,020 shares of the company’s stock after selling 12,456 shares during the period. Dimensional Fund Advisors LP owned 0.07% of Beauty Health worth $142,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of SKIN. Barclays PLC boosted its position in shares of Beauty Health by 224.7% during the third quarter. Barclays PLC now owns 106,103 shares of the company’s stock valued at $153,000 after buying an additional 73,425 shares during the last quarter. SG Americas Securities LLC raised its holdings in Beauty Health by 38.2% during the 4th quarter. SG Americas Securities LLC now owns 35,290 shares of the company’s stock valued at $56,000 after acquiring an additional 9,749 shares during the period. Newman Dignan & Sheerar Inc. increased its position in shares of Beauty Health by 39.1% during the fourth quarter. Newman Dignan & Sheerar Inc. now owns 71,144 shares of the company’s stock valued at $113,000 after buying an additional 20,000 shares during the period. Charles Schwab Investment Management Inc. raised its position in shares of Beauty Health by 7.1% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 688,365 shares of the company’s stock worth $1,094,000 after buying an additional 45,525 shares in the last quarter. Finally, Raymond James Financial Inc. bought a new stake in Beauty Health during the fourth quarter valued at approximately $25,000. Institutional investors own 93.26% of the company’s stock.

Beauty Health Stock Performance

Shares of SKIN opened at $1.74 on Friday. The company has a debt-to-equity ratio of 9.23, a current ratio of 6.56 and a quick ratio of 5.57. The Beauty Health Company has a one year low of $0.78 and a one year high of $2.76. The firm has a market capitalization of $217.93 million, a PE ratio of -4.14 and a beta of 0.88. The company has a 50-day simple moving average of $1.21 and a two-hundred day simple moving average of $1.45.

Beauty Health (NASDAQ:SKIN) last released its earnings results on Thursday, May 8th. The company reported ($0.08) EPS for the quarter, topping analysts’ consensus estimates of ($0.13) by $0.05. Beauty Health had a negative return on equity of 44.83% and a negative net margin of 8.11%. The firm had revenue of $69.60 million for the quarter, compared to analysts’ expectations of $63.88 million. On average, analysts anticipate that The Beauty Health Company will post -0.25 EPS for the current fiscal year.

Analysts Set New Price Targets

Separately, Canaccord Genuity Group lowered their price target on shares of Beauty Health from $1.50 to $1.25 and set a “hold” rating for the company in a research note on Monday, May 5th.

Beauty Health Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.